Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
Health & Biotech
Health: Immuron takes a dive after drug fails in alcoholic hepatitis trial
Health & Biotech
Health: PainChek wants to know if its app can detect pain in babies
Health & Biotech
What’s next for Telix after biggest drug IPO in 23 years
Health & Biotech
Too small for Nasdaq, too big for VC: Telix up 18pc in ASX debut after $50m IPO
Health & Biotech
